Lazarex Cancer Foundation

Providing advanced cancer patients access to clinical trials.

Category:

Danville, CA – EIN 202562494 lazarex.org

Vision
The vision of Lazarex Cancer Foundation is that everyone affected by cancer will have hope, dignity, support and the most advanced treatments made available to them at all stages of their journey.

What We Do
At Lazarex Cancer Foundation we improve the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement. We provide resources for cancer patients who have been told they have no other options, but who are not yet done with their journey in life and refuse to give up.

We help patients of all ages and walks of life, with all forms of cancer.
We help patients take advantage of medical breakthroughs today, because they may not have a tomorrow.
We believe that the size of a patient’s bank account should not stand between them and the choices they make or the treatments they need.
We present clinical trials as an alternative to hospice care for those who want to remain engaged in their fight against cancer.
We aspire to improve cancer survival rates through screenings and early detection, with a focus on the medically underserved to address health disparities.
Meet our VIPs (Very Important Patients)

“So many dreams at first seem impossible, then they seem improbable, and then, when we summon the will, they soon become inevitable.”

– Christopher Reeve
Why Lazarex? What Makes Us Unique?
Lazarex is the only 501(c)(3) public charity that does what we do. We focus on helping patients with all types of cancer, of all ages, from all walks of life. We promote early stage diagnosis to increase survival, especially for the medically underserved. We remove the barriers to clinical trial participation for advanced stage patients seeking life through FDA clinical trials. For these patients Lazarex is literally their last line of defense.

Non-Discrimination Policy: Patient Services:
Lazarex Cancer Foundation is committed to the principles of equal access to services. Lazarex prohibits discrimination against any person on the basis of race, color, national origin, age, disability, sexual orientation, gender or gender expression, marital, familial, or parental status, religion, genetic information, military status, political beliefs, or any other status protected under local, state, or federal law, in connection with its programs and activities. This policy extends to all personnel decisions, terms and conditions of employment, vendor contracts, and the provision of services. We are committed to providing an inclusive and welcoming environment for all members of our staff, volunteers, subcontractors, vendors, and patients.

LCF Statement on Diversity and Racial Equity
The escalating climate of intolerance and racism toward the Black community, highlighted by the very public and unjustified killing of George Floyd and many others has catalyzed people of all colors worldwide to address the undeniable deep roots of racism in our society. Many of us are getting an education like no other, leaving no doubt that racial injustice is not a black or brown problem, it is a problem that belongs to all of us.

“Until we are all free, we are none of us free.”

Emma Lazarus

At Lazarex Cancer Foundation we continue our work to address systemic racism in the healthcare system by highlighting the barriers that perpetuate it and working with stakeholders to dismantle them. We acknowledge that racial equity is not yet a reality. It is ingrained in our mission to fight for equitable access to quality cancer healthcare for all people, with a focus on minorities and the medically underserved. We stand in support of the Black community and will continue to do our part to fight for racial justice.

While cancer does not discriminate, Black, Asian, Latinx, Pacific Islanders and Native Americans face disproportionately higher rates of mortality from cancers that could be survived when diagnosed and treated early. But racism, poverty, low wages, language, cultural barriers, and lack of access to good nutrition are barriers to wellness, cancer prevention, diagnosis, and treatment. This is fundamentally and morally wrong.

Lazarex Cancer Foundation will remain steadfast to our mission to help cancer patients participate in FDA therapeutic clinical trials and undergo a thoughtful, thorough self-examination to identify where we can do more to create an environment of equity within our organization, our relationships, and the services we provide. We will hold ourselves accountable and look forward to sharing our findings and plan with you.

Tweets

Videos

IRS data by ProPublica Nonprofit Explorer


LAZAREX CANCER FOUNDATION

DANVILLE, CA 94526-4048 | Tax-exempt since Jan. 2006
  • EIN: 20-2562494
  • Classification (NTEE)
    Educational Services and Schools - Other (Educational Institutions and Related Activities)
  • Nonprofit Tax Code Designation: 501(c)(3)
    Defined as: Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn’t provide athletic facilities or equipment), or the prevention of cruelty to children or animals.
  • Donations to this organization are tax deductible.
Fiscal year ending

Dec. 2018

Fiscal year ending Dec.

2018

Full Text

990 (filed on Jan. 23, 2020)

Full Filing

Raw XML

990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.

Fiscal year ending

Dec. 2017

Fiscal year ending Dec.

2017

Full Text

990 (filed on Nov. 15, 2018)

Full Filing

Raw XML

990

Total Revenue

$5,363,364

Total Functional Expenses $3,327,912
Net income $2,035,452
Notable sources of revenue Percent of total revenue
Contributions $5,108,926 95.3%
Program services $0
Investment income $1,134 0.0%
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $252,034 4.7%
Sales of assets $0
Net inventory sales $0
Other revenue $1,270 0.0%
Notable expenses Percent of total expenses
Executive compensation $22,837 0.7%
Professional fundraising fees $0
Other salaries and wages $470,019 14.1%
Other
Total Assets $2,618,928
Total Liabilities $199,136
Net Assets $2,419,792
Fiscal year ending

Dec. 2016

Fiscal year ending Dec.

2016

Full Text

990 (filed on Sept. 20, 2017)

Full Filing

Raw XML

990

Total Revenue

$2,489,068

Total Functional Expenses $2,603,642
Net income -$114,574
Notable sources of revenue Percent of total revenue
Contributions $2,107,741 84.7%
Program services $0
Investment income $686 0.0%
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $366,980 14.7%
Sales of assets $0
Net inventory sales $0
Other revenue $13,661 0.5%
Notable expenses Percent of total expenses
Executive compensation $0
Professional fundraising fees $0
Other salaries and wages $488,932 18.8%
Other
Total Assets $589,566
Total Liabilities $205,226
Net Assets $384,340
Fiscal year ending

Dec. 2015

Fiscal year ending Dec.

2015

PDF

990

Full Text

990 (filed on Aug. 30, 2016)

Full Filing

Raw XML

990

Total Revenue

$2,369,189

Total Functional Expenses $2,268,397
Net income $100,792
Notable sources of revenue Percent of total revenue
Contributions $1,812,831 76.5%
Program services $0
Investment income $17 0.0%
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $556,341 23.5%
Sales of assets $0
Net inventory sales $0
Other revenue $0
Notable expenses Percent of total expenses
Executive compensation $0
Professional fundraising fees $0
Other salaries and wages $371,405 16.4%
Other
Total Assets $679,797
Total Liabilities $180,883
Net Assets $498,914
Fiscal year ending

Dec. 2014

Fiscal year ending Dec.

2014

PDF

990

Full Text

990 (filed on Aug. 20, 2015)

Full Filing

Raw XML

990

Total Revenue

$2,380,055

Total Functional Expenses $2,142,113
Net income $237,942
Notable sources of revenue Percent of total revenue
Contributions $1,919,463 80.6%
Program services $0
Investment income $0
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $460,592 19.4%
Sales of assets $0
Net inventory sales $0
Other revenue $0
Notable expenses Percent of total expenses
Executive compensation $0
Professional fundraising fees $0
Other salaries and wages $237,467 11.1%
Other
Total Assets $641,975
Total Liabilities $243,853
Net Assets $398,122
Fiscal year ending

Dec. 2013

Fiscal year ending Dec.

2013

PDF

990

Full Text

990 (filed on Oct. 23, 2014)

Full Filing

Raw XML

990

Total Revenue

$983,956

Total Functional Expenses $1,316,664
Net income -$332,708
Notable sources of revenue Percent of total revenue
Contributions $629,506 64.0%
Program services $0
Investment income $0
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $354,450 36.0%
Sales of assets $0
Net inventory sales $0
Other revenue $0
Notable expenses Percent of total expenses
Executive compensation $0
Professional fundraising fees $0
Other salaries and wages $226,730 17.2%
Other
Total Assets $341,722
Total Liabilities $181,542
Net Assets $160,180
Fiscal year ending

Dec. 2012

Fiscal year ending Dec.

2012

PDF

990

Raw XML

990

Total Revenue

$752,276

Total Functional Expenses $780,573
Net income -$28,297
Notable sources of revenue Percent of total revenue
Contributions $663,341 88.2%
Program services $0
Investment income $21 0.0%
Bond proceeds $0
Royalties $0
Rental property income $646 0.1%
Net fundraising $88,268 11.7%
Sales of assets $0
Net inventory sales $0
Other revenue $0
Notable expenses Percent of total expenses
Executive compensation $0
Professional fundraising fees $0
Other salaries and wages $167,010 21.4%
Other
Total Assets $526,428
Total Liabilities $33,540
Net Assets $492,888
Fiscal year ending

Dec. 2011

Fiscal year ending Dec.

2011

PDF

990

Total Revenue

$955,157

Total Functional Expenses $438,322
Net income $516,835
Notable sources of revenue Percent of total revenue
Contributions $925,240 96.9%
Program services $0
Investment income $158 0.0%
Bond proceeds $0
Royalties $0
Rental property income $0
Net fundraising $29,759 3.1%
Sales of assets $0
Net inventory sales $0
Other revenue $0
Notable expenses Percent of total expenses
Executive compensation $30,650 7.0%
Professional fundraising fees $0
Other salaries and wages $51,355 11.7%
Other
Total Assets $531,786
Total Liabilities $10,601
Net Assets $521,185
Fiscal year ending

Dec. 2010

Fiscal year ending Dec.

2010

PDF

990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.

Fiscal year ending

Dec. 2009

Fiscal year ending Dec.

2009

PDF

990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.

Fiscal year ending

Dec. 2008

Fiscal year ending Dec.

2008

PDF

990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.

Fiscal year ending

Dec. 2007

Fiscal year ending Dec.

2007

PDF

990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.

Fiscal year ending

Dec. 2006

Fiscal year ending Dec.

2006

PDF

990
990

Form 990 documents available

Extracted filing data is not available for this tax period, but Form 990 documents are available for download.


Last Updated: 2021-01-23 08:04
Scroll to Top